Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Prevalence of eosinophilic gastroenteritis and colitis

November's issue of the Clinical Gastroenterology & Hepatology investigates the prevalence of eosinophilic gastroenteritis and colitis in a population-based study.

News image

Although eosinophilic esophagitis has been extensively studied, there have been few epidemiology studies of other eosinophilic gastrointestinal disorders.

Using a large, population-based database, Dr Emad Mansoor and colleagues investigated epidemiologic features of eosinophilic gastroenteritis, and eosinophilic colitis in the United State.

The researchers collected data from a commercial database that provided electronic health records from 26 major integrated U.S. healthcare systems from 1999 to 2017.

The researchers identified a cohort of adult and pediatric patients with eosinophilic gastroenteritis and eosinophilic colitis from 2012 to March 2017, based on the Systematized Nomenclature of Medicine Clinical Terms.

The team calculated the overall prevalence of eosinophilic gastroenteritis and eosinophilic colitis among different patient groups, and performed age- and gender-adjusted analyses to assess for differences in the prevalence of associated medical conditions in patients with eosinophilic gastroenteritis and eosinophilic colitis and control patients.

The overall prevalence rate of eosinophilic colitis was 2 per 100,000 persons
Clinical Gastroenterology & Hepatology

Of the 35,826,830 individuals in the database, the researchers identified 1820 patients with eosinophilic gastroenteritis and 770 with eosinophilic colitis.

The researchers noted that the overall prevalence rate of eosinophilic gastroenteritis was 5 per 100,000 persons.

The team found that the overall prevalence rate of eosinophilic colitis was 2 per 100,000 persons.

Each of the non-eosinophilic esophagitis eosinophilic gastrointestinal disorders was more prevalent in Caucasians than in African-Americans and Asians, and in female patients than male patients.

Although eosinophilic gastroenteritis was more prevalent in children than in adults, eosinophilic colitis was more prevalent in adults.

Compared with control patients, the team observed that individuals with non-eosinophilic esophagitis eosinophilic gastrointestinal disorders were more likely to have been diagnosed with other gastrointestinal or allergic disorders.

Dr Mansoor's team comments, "In a population-based study in the United States, using the Explorys database, we found the overall prevalence rate of eosinophilic gastroenteritis to be 5 per 100,000 persons and the prevalence rate of eosinophilic colitis to be 2 per 100,000."

"These values are at the lower end of prevalence rates previously reported in the United States."

Clin Gastroenterol Hepatol 2017: 15(11): 1733–1741
14 November 2017

Go to top of page Email this page Email this page to a colleague

 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Socioeconomic characteristics in diverticular disease
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Barriers to hepatitis C treatment
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 31 October 2017 
Endoscopic indices of disease activity for Crohn’s
 31 October 2017 
Follow-up of positive results on fecal blood tests
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Hospital readmissions reduction program
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us